ask="5.32"
ask_size="300"
average_daily_volume="196567"
bid="5.19"
bid_size="100"
book_value="0.00"
change="-0.09"
change_from_200_day_moving_average="0.29"
change_from_50_day_moving_average="0.87"
change_from_52_week_high="-4.43"
change_From_52_week_low="2.24"
change_in_percent="-1.67%"
close="5.29"
dividend_pay_date="8/1/2016"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-4.18"
ebitda="0.00"
eps_estimate_current_year="-3.89"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="-5.48"
ex_dividend_date="N/A"
float_shares="N/A"
high="5.37"
high_52_weeks="9.72"
last_trade_date="1/12/2017"
last_trade_price="5.29"
last_trade_size="150"
last_trade_time="3:59pm"
low="5.18"
low_52_weeks="3.05"
market_capitalization="N/A"
moving_average_200_day="5.00"
moving_average_50_day="4.42"
name="Cyclacel Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="60.00"
open="5.37"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+5.84%"
percent_change_from_50_day_moving_average="+19.81%"
percent_change_from_52_week_high="-45.58%"
percent_change_from_52_week_low="+73.44%"
previous_close="5.38"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="N/A"
short_ratio="0.00"
stock_exchange="NCM"
symbol="CYCC"
volume="28671"
weeks_range_52="3.05 - 9.72"
